Isoflavones reduce arterial stiffness: A placebo-controlled study in men and postmenopausal women

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 23, Issue 6, 2003, Pages 1066-1071

  Teede, Helena J ^a,c   McGrath, Barry P ^a   DeSilva, Lakmini ^a   Cehun, Marja ^b   Fassoulakis, Andriana ^b   Nestel, Paul J ^b  

^a MONASH UNIVERSITY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c DANDENONG HOSPITAL   (Australia)

Author keywords

Arterial stiffness; Blood prssure; Endothelial function; Isoflavones; Vascular cellular adhesion molecule 1

Indexed keywords

BIOCHANIN A; DAIDZEIN; FORMONONETIN; GENISTEIN; ISOFLAVONE; PLACEBO; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTERY COMPLIANCE; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CLOVER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MECHANISM; FEMALE; HEART PROTECTION; HUMAN; MALE; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; TABLET FORMULATION; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASODILATATION;

AGED; ARM; BLOOD PRESSURE; CROSS-OVER STUDIES; DIET; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; GENISTEIN; HUMANS; ISOFLAVONES; MALE; MIDDLE AGED; PHYTOESTROGENS; PLANT PREPARATIONS; POSTMENOPAUSE; REFERENCE VALUES; REGIONAL BLOOD FLOW; TRIFOLIUM; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR RESISTANCE; VASODILATION;

EID: 0037783250     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000072967.97296.4A     Document Type: Article

References (38)

1. Mendelsohn ME, Karas RH. Mechanisms of disease: the protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999;340:1801-1811.
2. Teede HJ. Hormone replacement therapy and the prevention of cardio-vascular disease. Hum Reprod Update. 2002;8:201-215.
3. Teede HJ, McGrath BP, Smolich JJ, Malan E, Kotsopoulos D, Liang YL, Peverill RE. Postmenopausal hormone replacement therapy increases both coagulation activity and fibrinolysis. Arterioscler Thromb Vasc Biol. 2000;20:1404-1409.
4. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 1998;280:605-613.
5. Morito K, Aomori T, Hirose T, Kinjo J, Hasegawa J, Ogawa S, Inoue S, Muramatsu M, Masamune Y. Interaction of phytoestrogens with estrogen receptors alpha and beta (II). Biol Pharm Bull. 2002;25:48-52.
6. Adlercreutz H. Epidemiology of phytoestrogens. Baillieres Clin Endocrinol Metab. 1998;12:605-623.
7. Teede HJ, Dalais F, Kotsopoulos D, Liang YL, McGrath BP. Soy protein dietary supplementation containing phytoestrogens improves lipid profiles and blood pressure: a double blind, randomised, placebo controlled study in men and postmenopausal women. J Clin Endocrinol Metab. 2001;86:3053-3060.
8. Honore EK, Williams JK, Anthony MS, Clarkson TB. Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques. Fertil Steril. 1997;67:148-154.
9. Nestel PJ, Yamashita T, Sasahara T, Pomeroy S, Dart A, Komesaroff P, Owen A, Abbey M. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol. 1997;17:3392-3398.
10. Nestel PJ, Pomeroy S, Kay S, Komesaroff P, Behrsing J, Cameron JD, West L. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in postmenopausal women. J Clin Endocrinol Metab. 1999;84:895-898.
11. Williams JK, Clarkson TB. Dietary soy isoflavones inhibit in-vivo constrictor responses of coronary arteries to collagen-induced platelet activation. Coron Artery Dis. 1998;9:759-764.
12. Simons LA, von Konigsmark M, Simons J, Celermajer DS. Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. Am J Cardiol. 2000;85:1297-1301.
13. Squadrito F, Altavilla D, Morabito N, Crisafulli A, D'Anna R, Corrado F, Ruggeri P, Campo GM, Calapi G, Caputi AP, Squadrito G. The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium dependent vasodilation in postmenopausal women. Atherosclerosis. 2002;163:339-347.
14. Van der Schouw YT, Pijpe A, Lebrun CEI, Bots ML, Peeters PHM, van Staveren WA, Lamberts WJ, Grobbee DE. Higher usual dietary intake of phytoestrogens is associated with lower aortic stiffness in postmenopausal women. Arterioscler Thromb Vasc Biol. 2002;22:1316-1322.
15. Van Popele NM, Grobbee DE, Bots ML, Asmar R, Topouchian J, Reneman RS, Hoeks AP, van der Kuip DA, Hofman A, Witteman JC. Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke. 2001;32:454-460.
16. Meaume S, Benetos A, Henry OF, Rudnici A, Safar ME. Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arteriscler Thromb Vasc Biol. 2001;21:2046-2050.
17. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, Laurent S. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002;39:10-15.
18. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99:2434-2439.
19. Liang Yu-Lu, Teede HJ, Kotsopoulos D, Shiel L, Cameron JD, Dart AM, McGrath BP. Non-invasive measurements of arterial structure and function: repeatability, interrelationships and trial sample size. Clin Sci. 1998;95:669-679.
20. Ludbrook J. Multiple comparison procedures updated. Clin Exp Pharmacol Physiol. 1998;25:1032-1037.
21. Tsunoda N, Pomeroy S, Nestel P. Absorption in humans of isoflavones from soy and red clover is similar. J Nutr. 2002;132:2199-2201.
22. King RA, Bursill DA. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am J Clin Nutr. 1998;67:867-872.
23. Setchell K D, Brown NM, Desai P, Zimmer-Nechemias L, Brashear WT, Kirschner AS, Cassidy A, Heubi JE. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr. 2001;131:1362S-1375S.
24. Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc'h PM, London GM. Central pulse pressure and mortality in end-stage renal disease. Hypertension. 2002;39:735-738.
25. Clarkson T, Anthony M, Klein K. Effects of estrogen treatment on arterial wall structure and function. Drugs. 1994;2:42-51.
26. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 1990;81:1680-1687.
27. Chin-Dusting JPF, Fisher L, Lewis TV, Piekarska A, Nestel P, Husband A. The vascular activity of some isoflavone metabolites: implications for a cardioprotective role. Br J Pharmacol. 2001;33:595-605.
28. Makela S, Savolainen H, Aavik E, Myllarniemi M, Strauss L, Taskinen E, Gustafsson JA, Hayry P. Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta. Proc Natl Acad Sci U S A. 1999;96:7077-7082.
29. Anthony MS, Clarkson TB, Bullock BC, Wagner JD. Soy Protein versus soy phytoestrogens in the prevention of diet induced coronary artery atherosclerosis of male cynamologous monkeys. Arterioscler Thromb Vasc Biol. 1997;17:2524-2531.
30. Walker HA, Dean TS, Sanders TAB. The phytoestrogen genistein produces acute nitric oxide-dependent dilation of human forearm vasculature with similar potency to 17β-estradiol. Circulation. 2001;103:258-262.
31. Koh KK, Blum A, Hathaway L. Vascular effects of estrogen and vitamin E therapies in postmenopausal women. Circulation. 1999;100:1851-1857.
32. Hansson GK. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol. 2001;21:1876-1890.
33. Rohde LE, Lee RT, Rivero J, Jamacochian M, Arroyo LH, Briggs W, Rifai N, Libby P, Creager MA, Ridker PM. Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 1998;18:1765-1770.
34. Blankenberg S, Rupprecht HJ, Bickel C, Peetz D, Hafner G, Tiret L, Meyer J. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation. 2001;104:1336-1342.
35. Hodgson JM, Puddey IB, Beilin LJ, Mori TA, Burke V, Croft KD, Rogers PB. Effects of isoflavonoids on blood pressure in subjects with high-normal ambulatory blood pressure levels: a randomized controlled trial. Am J Hypertens. 1999;2:47-53.
36. Teede HJ, Yu-Lu Liang, Dimitra Kotsopoulos, Sophia Zoungas, Craven R, Barry P McGrath. A placebo controlled trial of long-term oral combined continuous hormone replacement therapy in postmenopausal women: effects on arterial compliance and endothelial function. Clin Endocrinol. 2001;55:673-682.
37. Davis SR, Dalais FS, Simpson ER, Murkies AL. Phytoestrogens in health and disease. Recent Prog Horm Res. 1999;54:185-210.
38. Hughes CL, Chakinala MM, Reece SG, Miller RN, Schomberg DW, Basham KB. Acute and subacute effects of naturally occurring estrogens on luteinizing hormone secretion in the ovariectomized rat: Part 2. Reprod Toxicol. 1991;5:127-132.